Key objectives include determining long-term safety, identifying patient subgroups most likely to benefit, clarifying effects across HF phenotypes, and assessing patient-centered outcomes such as quality of life, functional status, and hospitalization burden
10.1016/j.redox.2024.103288 Redox Biol
Our job is to help you understand which category youre in and create a plan to shorten the shedding window, support regrowth, and protect your hair long term
Finally, we were not able to evaluate other GLP-1 receptor agonists such as dulaglutide and liraglutide because trials of these agents included very few, if any, participants receiving SGLT2 inhibitors at baseline
Who should not take GLP-1 drugs if they have stomach issues